Ear zap device could help clear hospital confusion
NCT ID NCT07258082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether a non-invasive device that gently stimulates a nerve in the ear (taVNS) is safe and practical for ICU patients with delirium—a state of confusion that can slow recovery. Ten right-handed adults with delirium will receive 30-minute sessions twice daily for up to 7 days, alongside usual care. Researchers will monitor side effects, brain signals, and oxygen levels to see if the approach is feasible and well-tolerated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stony Brook University Hospital
RECRUITINGStony Brook, New York, 11794, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dissolvable film quiet ICU delirium?
- A cheap blood marker might flag delirium risk in elderly surgery patients
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Isolation in hospital may cloud the minds of older patients — a study investigates
- Could wearable sensors spot delirium before doctors do?
- Can we predict brain fog in older women fighting ovarian cancer?